[
    {
        "id": 1,
        "text": "1.Phenoxybezamine與α 受體的結合可被視為： 1",
        "options": {
            "A": "全致效劑（full agonist）",
            "B": "部分致效劑（partial agonist）",
            "C": "競爭性拮抗劑（competitive antagonist）",
            "D": "非競爭性拮抗劑（non-competitive antagonist）"
        },
        "image": null,
        "images": []
    },
    {
        "id": 2,
        "text": "2.有關藥品命名的敘述，下列何者錯誤？",
        "options": {
            "A": "局部⿇醉劑常以「caine」結尾",
            "B": "β-blocker常以「olol」結尾",
            "C": "⽣物鹼（alkaloids）常以「ine」結尾",
            "D": "由Streptomyces所產⽣的抗⽣素，常以「micin」結尾"
        },
        "image": null,
        "images": []
    },
    {
        "id": 3,
        "text": "3.有關藥品名稱的敘述，下列何者錯誤？",
        "options": {
            "A": "meperidine和pethidine為相同的藥品",
            "B": "sulfamethazine和sulfadimidine為相同的藥品",
            "C": "acetaminophen和paracetamol為相同的藥品",
            "D": "ergonovine和ergometrine為不同的藥品"
        },
        "image": null,
        "images": []
    },
    {
        "id": 4,
        "text": "4.有關劑型的敘述，下列何者錯誤？",
        "options": {
            "A": "栓劑的溶解常和溫度相關",
            "B": "⼝服磨粉後的腸衣錠不能增加⽣體可⽤率（bioavailability）",
            "C": "1號膠囊的容量為0.5mL",
            "D": "⽔溶性軟膏的基質常為petrolatum"
        },
        "image": null,
        "images": []
    },
    {
        "id": 5,
        "text": "5.有關經⽪吸收（transdermal absorption）藥品的敘述，下列何者正確？",
        "options": {
            "A": "增加藥品的脂溶性，必可平⾏增加藥品的吸收",
            "B": "經⽪膚吸收的過程中皆不會發⽣藥品的代謝",
            "C": "因吸收緩慢，同⼀劑量的⽪膚貼布常能以相同的⽅式⽤於不同種別的動物",
            "D": "Fentanyl⽌痛貼布現已被使⽤於⽝、貓與⾺"
        },
        "image": null,
        "images": []
    },
    {
        "id": 6,
        "text": "6.有關投藥的敘述，下列何者正確？",
        "options": {
            "A": "除了靜脈注射外，其他任何給藥⽅式皆需要經過吸收步驟才會產⽣藥效",
            "B": "若能增快胃的排空速率，必能增加吸收⼝服藥品的百分率",
            "C": "投予的劑量（dose）為預測藥效的最佳⽅式",
            "D": "緩釋劑型常可保持較為穩定的⾎中濃度"
        },
        "image": null,
        "images": []
    },
    {
        "id": 7,
        "text": "7.有關靜脈注射barbital和thiopental的敘述，下列何者正確？",
        "options": {
            "A": "注射1分鐘後，barbital在腦中濃度較⾎中濃度為⾼",
            "B": "注射1分鐘後，thiopental在腦中濃度較⾎中濃度為⾼",
            "C": "注射1分鐘後，在腦中thiopental的濃度較barbital的濃度為⾼",
            "D": "barbital的脂溶性較thiopental為⾼"
        },
        "image": null,
        "images": []
    },
    {
        "id": 8,
        "text": "8.有關⾎漿蛋⽩結合特性的敘述，下列何者正確？",
        "options": {
            "A": "半衰期⻑的藥品皆是因藥品與⽩蛋⽩以共價鍵結合",
            "B": "與⾎漿蛋⽩結合的藥品⼀定無法經由腎臟排泄",
            "C": "嚴重的低⽩蛋⽩⾎症不會改變藥品的⽩蛋⽩結合率",
            "D": "在嚴重的肝硬化時，主要是降低酸性藥品和⽩蛋⽩結合"
        },
        "image": null,
        "images": []
    },
    {
        "id": 9,
        "text": "9.若擬於 60 L⽔量之⽔族箱中投予 25 ppm之A藥，購得含A藥有效成分 10%之藥劑，則應加入多少mL之該藥 劑，始能達到預期之效果？",
        "options": {
            "A": "0.15",
            "B": "1.5",
            "C": "15",
            "D": "30"
        },
        "image": null,
        "images": []
    },
    {
        "id": 10,
        "text": "10.影響藥物能否穿過⾎腦障壁（blood-brain barrier）的主要因素為何？",
        "options": {
            "A": "藥物的分⼦量",
            "B": "藥物的脂溶性",
            "C": "藥物的⽣體可⽤率",
            "D": "藥物的排除速率"
        },
        "image": null,
        "images": []
    },
    {
        "id": 11,
        "text": "11.⽣體可⽤率（bioavailability）愈⾼，代表投藥後：",
        "options": {
            "A": "脂肪組織中累積愈多",
            "B": "藥物半衰期愈⻑",
            "C": "藥物分布愈廣",
            "D": "能被吸收之藥物愈多"
        },
        "image": null,
        "images": []
    },
    {
        "id": 12,
        "text": "12.⻑時間使⽤某⼀藥品，藥效漸減⽽需增加劑量才能達到原始效果的現象稱為：",
        "options": {
            "A": "成癮性（addiction）",
            "B": "感受性（sensitivity）",
            "C": "專⼀性（specificity）",
            "D": "耐受性（tolerance）"
        },
        "image": null,
        "images": []
    },
    {
        "id": 13,
        "text": "13.下列何者是藥物動⼒學C 之意義？ max",
        "options": {
            "A": "藥物之最⼤代謝速率",
            "B": "藥物最⼤之分布容積",
            "C": "⾎漿中藥物之最⾼濃度",
            "D": "藥物所產⽣之最⼤效應"
        },
        "image": null,
        "images": []
    },
    {
        "id": 14,
        "text": "14.使⽤ketamine後的⿇醉恢復期，較易⾒的副作⽤為何？",
        "options": {
            "A": "呼吸抑制",
            "B": "低⾎壓",
            "C": "腎毒性",
            "D": "蹣跚興奮"
        },
        "image": null,
        "images": []
    },
    {
        "id": 15,
        "text": "15.下列何者不是α -受體的致效劑？ 2",
        "options": {
            "A": "xylazine",
            "B": "ranitidine",
            "C": "detomidine",
            "D": "medetomidine"
        },
        "image": null,
        "images": []
    },
    {
        "id": 16,
        "text": "16.下列何者對於增強肝臟P-450代謝酵素活性有最⼤效果？",
        "options": {
            "A": "amobarbital",
            "B": "secobarbital",
            "C": "pentobarbital",
            "D": "phenobarbital"
        },
        "image": null,
        "images": []
    },
    {
        "id": 17,
        "text": "17.吸入性⿇醉劑在肺泡中的氣體濃度下降速率愈快，則表⽰：",
        "options": {
            "A": "⽣物轉換速率愈快",
            "B": "⿇醉之恢復愈快",
            "C": "溶解度愈⼤",
            "D": "⿇醉劑之重分布"
        },
        "image": null,
        "images": []
    },
    {
        "id": 18,
        "text": "18.下列何者無法阻斷神經肌⾁接合處終板電位的產⽣？",
        "options": {
            "A": "succinylcholine",
            "B": "pancuronium",
            "C": "edrophonium",
            "D": "hemicholinium"
        },
        "image": null,
        "images": []
    },
    {
        "id": 19,
        "text": "19.有關scopolamine的使⽤，下列何者正確？",
        "options": {
            "A": "為⻑效型藥物",
            "B": "可治療因motion sickness引起的嘔吐",
            "C": "主要作⽤為拮抗α -受體 2",
            "D": "最常⽤於貓"
        },
        "image": null,
        "images": []
    },
    {
        "id": 20,
        "text": "20.下列何者為β -腎上腺素性受體活化後之主要藥理作⽤？ 1",
        "options": {
            "A": "散瞳",
            "B": "抑制唾液分泌",
            "C": "增加⼼跳速率",
            "D": "抑制肝醣分解"
        },
        "image": null,
        "images": []
    },
    {
        "id": 21,
        "text": "21.下列何者為經⼝投予phenylephrine之主要臨床⽤途？",
        "options": {
            "A": "解除⿐黏膜充⾎",
            "B": "治療腦性⾼⾎壓",
            "C": "治療鬱⾎性⼼衰竭",
            "D": "收縮瞳孔治療青光眼"
        },
        "image": null,
        "images": []
    },
    {
        "id": 22,
        "text": "22.下列治療⾼⾎壓的藥物，何者之作⽤機制為刺激腦幹神經細胞α 接受器，因⽽降低交感神經活性？ 2",
        "options": {
            "A": "reserpine",
            "B": "prazosin",
            "C": "guanethidine",
            "D": "clonidine"
        },
        "image": null,
        "images": []
    },
    {
        "id": 23,
        "text": "23.下列何者會抑制鈣離⼦流入⼼臟傳導系統的細胞？",
        "options": {
            "A": "amiodarone",
            "B": "atenolol",
            "C": "verapamil",
            "D": "flecainide"
        },
        "image": null,
        "images": []
    },
    {
        "id": 24,
        "text": "24.下列何者為鈣離⼦阻斷劑，且能使⾎管平滑肌擴張？",
        "options": {
            "A": "amlodipine",
            "B": "minoxidil",
            "C": "atenolol",
            "D": "hydralazine"
        },
        "image": null,
        "images": []
    },
    {
        "id": 25,
        "text": "25.下列何者為使⽤enalapril後之主要藥理作⽤？",
        "options": {
            "A": "增加⼼肌收縮⼒",
            "B": "促進腎素（renin）分泌",
            "C": "擴張靜脈及⼩動脈",
            "D": "利尿⽽消除肺部積⽔"
        },
        "image": null,
        "images": []
    },
    {
        "id": 26,
        "text": "26.Chlorothiazide利尿劑主要作⽤於腎⼩管的那個部位？",
        "options": {
            "A": "近曲⼩管（proximal tubule）",
            "B": "收集管（collecting tubule）",
            "C": "亨利⽒環上昇端（ascending limb of the loop of Henle）",
            "D": "遠曲⼩管（distal tubule）"
        },
        "image": null,
        "images": []
    },
    {
        "id": 27,
        "text": "27.使⽤下列何種利尿劑可能引發⾼⾎鉀之副作⽤？",
        "options": {
            "A": "bumetanide",
            "B": "ethacrynic acid",
            "C": "hydrochlorothiazide",
            "D": "spironolactone"
        },
        "image": null,
        "images": []
    },
    {
        "id": 28,
        "text": "28.下列何者作⽤於亨利⽒環上昇端？",
        "options": {
            "A": "ethacrynic acid",
            "B": "amiloride",
            "C": "spironolactone",
            "D": "triamterene"
        },
        "image": null,
        "images": []
    },
    {
        "id": 29,
        "text": "29.下列何者之作⽤機制主要為抑制碳酸酐酶？",
        "options": {
            "A": "acetazolamide",
            "B": "aminophylline",
            "C": "furosemide",
            "D": "thiazides"
        },
        "image": null,
        "images": []
    },
    {
        "id": 30,
        "text": "30.下列何者是ranitidine促進胃腸蠕動的作⽤機轉？",
        "options": {
            "A": "刺激腸道神經",
            "B": "抑制⼄醯膽鹼酯酶（acetylcholinesterase）",
            "C": "阻斷組織胺（histamine）受體",
            "D": "阻斷多巴胺（dopamine）受體"
        },
        "image": null,
        "images": []
    },
    {
        "id": 31,
        "text": "31.下列影響腸胃功能的藥物中，何者最容易引起尿液滯留的副作⽤？",
        "options": {
            "A": "cimetidine",
            "B": "misoprostol",
            "C": "omeprazole",
            "D": "propantheline"
        },
        "image": null,
        "images": []
    },
    {
        "id": 32,
        "text": "32.下列何者經⼝投予⽝後，可能會導致糞便呈現⿊⾊？",
        "options": {
            "A": "bismuth subsalicylate",
            "B": "misoprostol",
            "C": "omeprazole",
            "D": "sucralfate"
        },
        "image": null,
        "images": []
    },
    {
        "id": 33,
        "text": "33.下列何者不具⽌吐作⽤？",
        "options": {
            "A": "dolasetron",
            "B": "droperidol",
            "C": "morphine",
            "D": "promethazine"
        },
        "image": null,
        "images": []
    },
    {
        "id": 34,
        "text": "34.下列⽀氣管擴張劑何者屬於非選擇性β-受體致效劑（nonselective β-receptor agonists）？",
        "options": {
            "A": "ephedrine",
            "B": "isoetharine",
            "C": "albuterol",
            "D": "terbutaline"
        },
        "image": null,
        "images": []
    },
    {
        "id": 35,
        "text": "35.下列那⼀種鴉片類藥物之鎮咳作⽤遠⼤於鎮痛作⽤？",
        "options": {
            "A": "codeine",
            "B": "fentanyl",
            "C": "morphine",
            "D": "hydromorphone"
        },
        "image": null,
        "images": []
    },
    {
        "id": 36,
        "text": "36.下列何種藥物不具有鎮咳作⽤？",
        "options": {
            "A": "hydrocodone",
            "B": "butorphanol",
            "C": "bromhexine HCl",
            "D": "dextromethorphan"
        },
        "image": null,
        "images": []
    },
    {
        "id": 37,
        "text": "37.下列何者是β -selective氣管擴張劑？ 2",
        "options": {
            "A": "epinephrine",
            "B": "terbutaline",
            "C": "isoproterenol",
            "D": "ephedrine"
        },
        "image": null,
        "images": []
    },
    {
        "id": 38,
        "text": "38.貓因下列何種因素⽽需⼩⼼使⽤NSAIDs藥物？",
        "options": {
            "A": "無法排泄此類藥物",
            "B": "NSAIDs對⾎中蛋⽩具⾼度結合⼒，致使藥物半衰期很⻑，容易有藥物蓄積中毒情形",
            "C": "cytochrome p450及葡萄醛酸接合系統不⾜",
            "D": "P-醣蛋⽩質排除效率低"
        },
        "image": null,
        "images": []
    },
    {
        "id": 39,
        "text": "39.下列何者為貓acetaminophen中毒時的最佳解毒劑？",
        "options": {
            "A": "atropine",
            "B": "acetylcysteine",
            "C": "physostigmine",
            "D": "pralidoxime"
        },
        "image": null,
        "images": []
    },
    {
        "id": 40,
        "text": "40.下列何者主要作⽤於⾎清素的受體？",
        "options": {
            "A": "atropine",
            "B": "cloprostenol",
            "C": "captopril",
            "D": "ketanserin"
        },
        "image": null,
        "images": []
    },
    {
        "id": 41,
        "text": "41.下列何者具有⾎管擴張活性？",
        "options": {
            "A": "bradykinin",
            "B": "diphenhydramine",
            "C": "ouabain",
            "D": "digitoxin"
        },
        "image": null,
        "images": []
    },
    {
        "id": 42,
        "text": "42.下列何者可⽤於治療副甲狀腺功能低下症？",
        "options": {
            "A": "dihydrotachysterol",
            "B": "calcitonin",
            "C": "levothyroxine",
            "D": "liothyronine"
        },
        "image": null,
        "images": []
    },
    {
        "id": 43,
        "text": "43.下列何者因需在動物體內轉化後才具有活性，故應避免使⽤於貓？",
        "options": {
            "A": "prednisone",
            "B": "prednisolone",
            "C": "hydrocortisone",
            "D": "deoxycorticosterone"
        },
        "image": null,
        "images": []
    },
    {
        "id": 44,
        "text": "44.下列何者屬⻑效型glucocorticoids？",
        "options": {
            "A": "hydrocortisone",
            "B": "cortisone",
            "C": "triamcinolone",
            "D": "dexamethasone"
        },
        "image": null,
        "images": []
    },
    {
        "id": 45,
        "text": "45.⾁食獸因下列何種維⽣素被不飽和脂肪酸破壞⽽缺乏時，易發⽣脂肪組織炎？",
        "options": {
            "A": "A",
            "B": "B",
            "C": "D",
            "D": "E"
        },
        "image": null,
        "images": []
    },
    {
        "id": 46,
        "text": "46.下列何者與體內鈣、磷的代謝控制無關？",
        "options": {
            "A": "parathyroid hormone",
            "B": "calcitonin",
            "C": "vitamine D",
            "D": "phytonadione"
        },
        "image": null,
        "images": []
    },
    {
        "id": 47,
        "text": "47.下列何者含有動物體內⼤部分的鐵？",
        "options": {
            "A": "globulin",
            "B": "hemoglobin",
            "C": "thyroxine",
            "D": "ceruloplasmin"
        },
        "image": null,
        "images": []
    },
    {
        "id": 48,
        "text": "48.家禽缺乏下列何種礦物質，會引起脫腱症、脛骨踝畸形與腓腸肌異位？",
        "options": {
            "A": "fluorine",
            "B": "copper",
            "C": "chromium",
            "D": "manganese"
        },
        "image": null,
        "images": []
    },
    {
        "id": 49,
        "text": "49.下列何者之作⽤機制為抑制病毒的核糖核蛋⽩進入宿主細胞？",
        "options": {
            "A": "amantadine",
            "B": "zidovudine",
            "C": "oseltamivir",
            "D": "famciclovir"
        },
        "image": null,
        "images": []
    },
    {
        "id": 50,
        "text": "50.下列何者為idoxuridine的作⽤機制？",
        "options": {
            "A": "防⽌病毒轉錄後的轉譯作⽤",
            "B": "終⽌病毒的DNA的合成",
            "C": "抑制神經胺酸酶",
            "D": "抑制病毒脫殼"
        },
        "image": null,
        "images": []
    },
    {
        "id": 51,
        "text": "51.於產食性經濟動物屠宰前之停藥期間，主要由下列那⼀因素所決定？",
        "options": {
            "A": "給藥之間隔",
            "B": "給藥之途徑",
            "C": "藥物之吸收速率",
            "D": "組織之殘留期間"
        },
        "image": null,
        "images": []
    },
    {
        "id": 52,
        "text": "52.Fluoroquinolones對敏感性細菌於增殖時，主要造成下列何種變化？",
        "options": {
            "A": "細胞壁不完整",
            "B": "細胞膜破裂",
            "C": "DNA裂解",
            "D": "蛋⽩質胺基酸變異"
        },
        "image": null,
        "images": []
    },
    {
        "id": 53,
        "text": "53.下列那⼀藥物為耐酸⽽可以⼝服給予之廣效性青黴素？",
        "options": {
            "A": "methicillin",
            "B": "ticarcillin",
            "C": "amoxicillin",
            "D": "penicillin G"
        },
        "image": null,
        "images": []
    },
    {
        "id": 54,
        "text": "54.單環內醯胺類（monobactams）藥物，主要使⽤於治療下列何種微⽣物之嚴重感染？",
        "options": {
            "A": "⾰蘭⽒陰性菌",
            "B": "⾰蘭⽒陽性菌",
            "C": "黴漿菌",
            "D": "原蟲"
        },
        "image": null,
        "images": []
    },
    {
        "id": 55,
        "text": "55.下列何者的作⽤機制與細菌核糖體30S次單位體無關？",
        "options": {
            "A": "oxytetracycline",
            "B": "neomycin",
            "C": "chloramphenicol",
            "D": "kanamycin"
        },
        "image": null,
        "images": []
    },
    {
        "id": 56,
        "text": "56.Tetracyclines對下列何者較無治療效果？",
        "options": {
            "A": "Haemobartonella spp.",
            "B": "Ehrlichia spp.",
            "C": "Borelia spp.",
            "D": "Clostridium spp."
        },
        "image": null,
        "images": []
    },
    {
        "id": 57,
        "text": "57.下列何種macrolides臨床上使⽤會造成⼼臟毒性？",
        "options": {
            "A": "tilmicosin",
            "B": "tylosin",
            "C": "clarithromycin",
            "D": "tildipirosin"
        },
        "image": null,
        "images": []
    },
    {
        "id": 58,
        "text": "58.Carbadox劑量過⾼易引起保育豬⽣⻑遲緩、便秘、脫⽔等不良反應，其原因與下列何者有關？",
        "options": {
            "A": "hypernatremia",
            "B": "hypercalcemia",
            "C": "hypoinsulinemia",
            "D": "hypoaldosteronism"
        },
        "image": null,
        "images": []
    },
    {
        "id": 59,
        "text": "59.下列何者屬於glycopeptide類抗菌劑？",
        "options": {
            "A": "ronidazole",
            "B": "pirlimycin",
            "C": "spectinomycin",
            "D": "vancomycin"
        },
        "image": null,
        "images": []
    },
    {
        "id": 60,
        "text": "60.下列何項組合可⽤於治療由Rhodococcus equi引起⾺的肺炎？",
        "options": {
            "A": "clarithromycin+rifampin",
            "B": "cefoxitin+clindamycin",
            "C": "flucytosine+amphotericin B",
            "D": "penicillin+streptomycin"
        },
        "image": null,
        "images": []
    },
    {
        "id": 61,
        "text": "61.某⽝服⽤某藥物後產⽣跛⾏、聽⼒受損、⽪膚發疹、蛋⽩尿及⾎液學檢查有BUN、creatinine增加情況，其最 有可能為服⽤下列何種藥物中毒所致？",
        "options": {
            "A": "macrolides",
            "B": "lincosamides",
            "C": "aminoglycosides",
            "D": "tetracyclines"
        },
        "image": null,
        "images": []
    },
    {
        "id": 62,
        "text": "62.下列何者為vincristine毒殺腫瘤細胞的主要作⽤機制？",
        "options": {
            "A": "抑制胸腺嘧啶核苷酸合成酶（thymidylate synthase）",
            "B": "抑制細胞有絲分裂紡錘體微管的形成",
            "C": "抑制核糖核苷酸還原酶（ribonucleotide reductase）",
            "D": "抑制第⼆型拓樸異構酶（topoisomerase-II）"
        },
        "image": null,
        "images": []
    },
    {
        "id": 63,
        "text": "63.⽝隻使⽤cyclophosphamide，⽣物轉化產⽣acrolein最可能引起下列何種毒性？",
        "options": {
            "A": "⼼肌病變",
            "B": "肺纖維化",
            "C": "膀胱炎",
            "D": "神經病變"
        },
        "image": null,
        "images": []
    },
    {
        "id": 64,
        "text": "64.Rimantadine抗病毒作⽤機制是：",
        "options": {
            "A": "抑制病毒顆粒組裝",
            "B": "⼲擾病毒合成蛋⽩質",
            "C": "⼲擾病毒合成DNA",
            "D": "抑制reverse transcriptase"
        },
        "image": null,
        "images": []
    },
    {
        "id": 65,
        "text": "65.⼤多數抗腫瘤藥物會影響骨髓的造⾎機能，原因為何？",
        "options": {
            "A": "藥物促使腫瘤細胞轉移⾄骨髓",
            "B": "藥物抑制骨髓細胞的分裂",
            "C": "藥物殺死腫瘤細胞時釋放出毒性物質所致",
            "D": "藥物引起的過敏性反應"
        },
        "image": null,
        "images": []
    },
    {
        "id": 66,
        "text": "66.下列何者為抑菌性抗⽣素？",
        "options": {
            "A": "amoxicillin",
            "B": "oxytetracycline",
            "C": "bacitracin",
            "D": "streptomycin"
        },
        "image": null,
        "images": []
    },
    {
        "id": 67,
        "text": "67.下列何種抗菌劑為作⽤於30S核糖體次單位，且⼝服吸收差？",
        "options": {
            "A": "paromomycin",
            "B": "tylosin",
            "C": "clindamycin",
            "D": "rifampin"
        },
        "image": null,
        "images": []
    },
    {
        "id": 68,
        "text": "68.為降低難溶性磺胺劑在泌尿系統中產⽣結⽯，下列處置何者錯誤？",
        "options": {
            "A": "併⽤同類藥",
            "B": "供給充分⽔分",
            "C": "降低尿液的pH值",
            "D": "併⽤NaHCO 3"
        },
        "image": null,
        "images": []
    },
    {
        "id": 69,
        "text": "69.下列何者為外寄⽣蟲殺滅劑？",
        "options": {
            "A": "naphazoline",
            "B": "lodoxamide",
            "C": "dinotefuran",
            "D": "hirudin"
        },
        "image": null,
        "images": []
    },
    {
        "id": 70,
        "text": "70.下列何者⽤於噴灑於家⽤物及動物⾝上，以預防跳蚤之蟲卵、蛹及幼蟲發育為成體？",
        "options": {
            "A": "methoprene",
            "B": "methoxychlor",
            "C": "methotrexate",
            "D": "methohexital"
        },
        "image": null,
        "images": []
    },
    {
        "id": 71,
        "text": "71.下列何者能有效及安全治療兔疥癬症？",
        "options": {
            "A": "dorzolamide",
            "B": "acetazolamide",
            "C": "doramectin",
            "D": "glycopyrrolate"
        },
        "image": null,
        "images": []
    },
    {
        "id": 72,
        "text": "72.臨床上，對於貓分離出Malassezia spp.的外⽿道炎，下列何者為最佳醫療⽅案？",
        "options": {
            "A": "⼝服tacrolimus",
            "B": "肌⾁注射amphotericin B",
            "C": "局部塗抹nystatin",
            "D": "局部塗抹imiquimod"
        },
        "image": null,
        "images": []
    },
    {
        "id": 73,
        "text": "73.下列何者為amphotericin B併⽤itraconazole的主要⽬的？",
        "options": {
            "A": "不會進入體循環",
            "B": "皆為⼝服投藥⽅便且有加乘作⽤",
            "C": "降低腎毒性",
            "D": "治療⽝和貓的腎上腺⽪質機能亢進症"
        },
        "image": null,
        "images": []
    },
    {
        "id": 74,
        "text": "74.下列何者結合⾄DNA並⼲擾寄⽣蟲複製，可⽤於治療⽝焦蟲症？",
        "options": {
            "A": "dichlorophene",
            "B": "clorsulon",
            "C": "imidocarb",
            "D": "fenthion"
        },
        "image": null,
        "images": []
    },
    {
        "id": 75,
        "text": "75.下列何種酵素受到ketoconazole的抑制？",
        "options": {
            "A": "cytochrome P-450",
            "B": "monoamine oxidase",
            "C": "cholinesterase",
            "D": "cyclooxygenase"
        },
        "image": null,
        "images": []
    },
    {
        "id": 76,
        "text": "76.Amphotericin B與黴菌細胞膜中何種固醇類的結合⼒特別強？",
        "options": {
            "A": "tetrahymanol",
            "B": "sitosterol",
            "C": "cholesterol",
            "D": "ergosterol"
        },
        "image": null,
        "images": []
    },
    {
        "id": 77,
        "text": "77.下列何者為治療⽝隻慢性銅中毒的⾸選解毒劑？",
        "options": {
            "A": "penicillamine",
            "B": "sodium thiosulfate",
            "C": "methylpyrazole",
            "D": "phytonadione"
        },
        "image": null,
        "images": []
    },
    {
        "id": 78,
        "text": "78.Desferrioxamine緩慢的靜脈點滴注射⽤以治療下列何種⾦屬中毒？",
        "options": {
            "A": "鐵",
            "B": "銅",
            "C": "汞",
            "D": "鎘"
        },
        "image": null,
        "images": []
    },
    {
        "id": 79,
        "text": "79.在治療氰化物（cyanide）中毒時，下列何者為佳？",
        "options": {
            "A": "ascorbic acid－oral",
            "B": "sodium nitrite－IV",
            "C": "methylene blue－SC",
            "D": "phytonadione－IM"
        },
        "image": null,
        "images": []
    },
    {
        "id": 80,
        "text": "80.有關有機氯殺蟲劑的敘述，下列何者錯誤？",
        "options": {
            "A": "易溶於⽔親脂性",
            "B": "環境中殘留時間⻑",
            "C": "易儲存於脂肪中",
            "D": "幼齡動物較老年動物感受性強"
        },
        "image": null,
        "images": []
    }
]